Fw: [diseasesurveillance] Fw: ethical issue on DOTS/RNTCP

[Guest guest]

Ethical issue on DOTS/RNTCP. Please scroll down and go through the attachment.

 

Thank you very much.

 

Nikhil

Dr. Surender N. Gupta,

MBBS; PGDHHM;PGDMCH;PGCHFWM; FAIMS;FIMS;MA (Phil);MAE (Epidemiology) Faculty, Regional Health and Family Welfare Training Centre, CHHEB, Kangra-Himachal Pradesh, India. Pin-176001.

01892-265472 (Fax); 01892-263472 (Office)Mobile: 094181-28634.

E-mail IDs: drsurendernikhil

drnikhilsurender

--- On Sun, 1/24/10, surendernikhil gupta <drsurendernikhil wrote:

surendernikhil gupta <drsurendernikhilRe: [diseasesurveillance] Fw: Email alert: January issue of the WHO Â Â Â Â Â Bulletin [1 Attachment]diseasesurveillance Cc: ss_nair, allindiamdmsdoctorsassociation , ifanet-india (AT) googl (DOT) comDate: Sunday, January 24, 2010, 4:26 PM

 

 

 

 

 

Sir, This paper on the ethical issue on DOTS/RNTCP is highly informative and educative as it is reflecting the distilled wisdom from your side on the holistic approach towards DOTS. Of course, you have beautifully underscored the importance of those 90% of the chest symptomatic who have not been adequately dealt due to compartmentalization approach and secondly, overdependence upon radiological findings than sputum microscopy. Thirdly, glaring fact from several studies is that at least two-thirds of cases were cured even with incomplete treatment and identification of cases needing no treatment, short treatment or full treatment.

And about the confusing story of the cured and completed treatment; cure rate and inflated success rate are also well taken care of and so on and so forth. Quite agreed on the point of the fetish for DOTS and the laissez faire attitude to ethical issues should be replaced by active measures to reduce unethical practices. Well done, Sir!! Thank you very much.

With warm personal regards,

 

Nikhil

Dr. Surender N. Gupta,

MBBS; PGDHHM;PGDMCH;PGCHFWM; FAIMS;FIMS;MA (Phil);MAE (Epidemiology) Faculty, Regional Health and Family Welfare Training Centre, CHHEB, Kangra-Himachal Pradesh, India. Pin-176001.

01892-265472 (Fax); 01892-263472 (Office)Mobile: 094181-28634.

E-mail IDs: drsurendernikhil

drnikhilsurender

--- On Sun, 1/24/10, S.S.NAIR <ss_nair wrote:

S.S.NAIR <ss_nairRe: [diseasesurveillance] Fw: Email alert: January issue of the WHO Â Â Â Â Â Bulletin [1 Attachment]diseasesurveillance Date: Sunday, January 24, 2010, 12:37 PM

 

 

Dear friends,

 

I have been an interested reader of the postings by members of the group. This has widened my knowledge on many topics discussed. Thanks a lot.

 

However, I feel that there has not been adequate coverage of ethical aspects. I am attaching an article on "Ethical Aspects of RNTCP". I hope this will be of interest to most of the members. A number of nonethical aspects have been pointed out in this article. May be, some of you will be shocked that such things are happenning and feel the need to rectify the grave mistakes. Lots needs to be done. Sugestions on how to go about these are welcome. One of the first steps is to create a wide awareness about these nonethical happennings. Let us start the ball rolling with determination so that the long fight needed will go on till success is reached.

 

There are many more nonethical occurrences in the health field. Indiscriminate use of diagnostic tests is quite common and probably obvious. Less obvious is the acceptance of these tests without questioning the sensitivity and specidficity of these tests, leading to both under and over diagonses.. Very often, the treatment given is based (or supported) by researech findings which are, sad to say, subtly influenced by powerful pharmaceutical companies. Based on your wide expereience more can be added.

 

 

Regards and best wishes

 

S.S.Nair

 

1 of 1 File(s)

 

 

 

 

 

ETHICAL